JOHN MCLAUGHLIN - 14 Jan 2022 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Director
Signature
/s/ Amy Trombly as attorney-in-fact
Issuer symbol
SNOA
Transactions as of
14 Jan 2022
Net transactions value
$0
Form type
4
Filing time
14 Jan 2022, 19:32:39 UTC
Next filing
30 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Stock option (right to buy) Award +30,000 +923% 33,252 14 Jan 2022 Common stock 30,000 $4.60 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control.
F2 The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors.